DK3773511T3 - Oral tablet til induceret spytproduktion - Google Patents

Oral tablet til induceret spytproduktion Download PDF

Info

Publication number
DK3773511T3
DK3773511T3 DK19729175.0T DK19729175T DK3773511T3 DK 3773511 T3 DK3773511 T3 DK 3773511T3 DK 19729175 T DK19729175 T DK 19729175T DK 3773511 T3 DK3773511 T3 DK 3773511T3
Authority
DK
Denmark
Prior art keywords
oral tablet
saliva production
induced saliva
induced
production
Prior art date
Application number
DK19729175.0T
Other languages
English (en)
Inventor
Helle Wittorff
Original Assignee
Fertin Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=66793731&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3773511(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fertin Pharma As filed Critical Fertin Pharma As
Application granted granted Critical
Publication of DK3773511T3 publication Critical patent/DK3773511T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK19729175.0T 2018-05-17 2019-05-15 Oral tablet til induceret spytproduktion DK3773511T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15/982,758 US11096894B2 (en) 2018-05-17 2018-05-17 Oral tablet for induced saliva generation
PCT/DK2019/050152 WO2019219142A1 (en) 2018-05-17 2019-05-15 An oral tablet for induced saliva generation

Publications (1)

Publication Number Publication Date
DK3773511T3 true DK3773511T3 (da) 2022-08-22

Family

ID=66793731

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19729175.0T DK3773511T3 (da) 2018-05-17 2019-05-15 Oral tablet til induceret spytproduktion

Country Status (13)

Country Link
US (1) US11096894B2 (da)
EP (2) EP4088716B1 (da)
JP (1) JP7403476B2 (da)
KR (1) KR102706980B1 (da)
CN (1) CN112118834B (da)
AU (1) AU2019269879B2 (da)
BR (1) BR112020023173A2 (da)
CA (1) CA3097055C (da)
DK (1) DK3773511T3 (da)
ES (1) ES2926159T3 (da)
MX (1) MX2020012280A (da)
PL (1) PL3773511T3 (da)
WO (1) WO2019219142A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11096896B2 (en) 2018-05-17 2021-08-24 Fertin Pharma A/S Tablet dosage form for buccal absorption of active ingredients
DK4146164T3 (da) * 2020-05-08 2025-05-26 Fertin Pharma As Flowpack til oral afgivelse af aktive ingredienser
WO2023241838A1 (de) * 2022-06-14 2023-12-21 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Kombinationstherapeutikum
DK202330231A1 (en) * 2023-09-27 2025-04-10 Fertin Pharma As Cannabidiol for alleviating xerostomia

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3070510A (en) 1959-11-03 1962-12-25 Procter & Gamble Dentifrice containing resinous cleaning agents
US3538230A (en) 1966-12-05 1970-11-03 Lever Brothers Ltd Oral compositions containing silica xerogels as cleaning and polishing agents
US3862307A (en) 1973-04-09 1975-01-21 Procter & Gamble Dentifrices containing a cationic therapeutic agent and improved silica abrasive
CA1080024A (en) * 1975-12-24 1980-06-24 Leonard Spooner Confection containing xylitol
US4340583A (en) 1979-05-23 1982-07-20 J. M. Huber Corporation High fluoride compatibility dentifrice abrasives and compositions
US4627977A (en) 1985-09-13 1986-12-09 Colgate-Palmolive Company Anticalculus oral composition
US4820506A (en) 1987-05-01 1989-04-11 Research Foundation, State University Of New York Salivary stimulant
US4997654A (en) 1989-08-14 1991-03-05 Warner-Lambert Company Method for increasing salivation for xerostomia patients
GB9100009D0 (en) 1991-01-02 1991-02-20 Cerestar Holding Bv Erythritol compositions
US5576014A (en) 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
TW469135B (en) 1995-10-03 2001-12-21 Chugai Pharmaceutical Co Ltd Chewable tablet
DE69738829D1 (de) 1996-07-12 2008-08-21 Daiichi Seiyaku Co Schnell zerfallende, druckgeformte Materialien sowie Prozess zu deren Herstellung
US6024981A (en) 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
GB9716432D0 (en) 1997-08-05 1997-10-08 Cerestar Holding Bv Tableting of erythritol
US5874068A (en) 1997-12-08 1999-02-23 Warner-Lambert Company Stabilized antiplaque and antigingivitis oral compositions containing N.sup.α -alkyl-L-arginine alkyl ester salts
CA2315088A1 (en) 1997-12-19 1999-07-01 Smithkline Beecham Corporation Process for manufacturing bite-dispersion tablets
AU1031500A (en) 1998-11-03 2000-05-22 Dandy A/S Sucrose fatty acid esters for use as increased release of active ingredients
FR2785538B1 (fr) 1998-11-06 2004-04-09 Prographarm Laboratoires Comprime a delitement rapide perfectionne
EP1365740A1 (en) 2001-02-08 2003-12-03 Pharmacia Corporation Rapid-onset medicament for the treatment of sexual dysfunction
KR20030081472A (ko) 2001-03-06 2003-10-17 교와 핫꼬 고교 가부시끼가이샤 구강내 속붕괴성 제제
SE0102197D0 (sv) 2001-06-20 2001-06-20 Pharmacia Ab New product and use and manufacture thereof
WO2003080023A2 (en) * 2002-03-20 2003-10-02 Elan Pharma International Limited Fast dissolving dosage forms having reduced friability
US20060147580A1 (en) 2003-02-04 2006-07-06 Vibeke Nissen Compressed chewing gum tablet
PL1737302T3 (pl) 2004-04-20 2018-05-30 Wm. Wrigley Jr. Company Odświeżające oddech produkty cukiernicze oraz sposoby ich wytwarzania i stosowania
WO2006034264A2 (en) 2004-09-21 2006-03-30 Applera Corporation Methods of using sulfur nucleophiles as improved alternatives to sodium bisulfite for methylated dna analysis
WO2006058250A2 (en) * 2004-11-24 2006-06-01 Spi Pharma, Inc. Orally disintegrating compositions
WO2006112961A2 (en) 2005-03-03 2006-10-26 Takasago International Corp. (Usa) Synergistic salivation components
CN1709229A (zh) 2005-06-10 2005-12-21 北京阜康仁生物制药科技有限公司 盐酸美金刚口腔崩解片及其制备方法
CN1891299B (zh) 2005-06-28 2012-06-27 上野制药株式会社 用于压片的糖醇组合物
DK2046300T3 (da) 2006-08-04 2010-07-26 Ethypharm Sa Oralt desintegrerende multilagstablet
WO2009007768A1 (en) 2007-07-06 2009-01-15 Gumlink A/S Compressed tablet comprising polyol
EP2264042B1 (en) 2007-07-27 2012-07-18 Cargill, Incorporated Micronization of polyols
WO2009080023A1 (en) 2007-12-20 2009-07-02 Fertin Pharma A/S Compressed chewing gum comprising peptide
WO2010025796A1 (en) 2008-09-04 2010-03-11 Cargill Incorporated Tabletting of ervthritol
US8617588B2 (en) 2009-03-09 2013-12-31 Spi Pharma, Inc. Highly compactable and durable direct compression excipients and excipient systems
US9591852B2 (en) 2009-11-23 2017-03-14 Mcneil-Ppc, Inc. Biofilm disruptive compositions
US8658139B1 (en) 2010-02-27 2014-02-25 Squigle, Inc. Prevention and treatment of oral diseases
CN107252419A (zh) 2010-12-22 2017-10-17 巴斯夫欧洲公司 快速崩解的固体包衣剂型
WO2013091631A1 (en) 2011-12-22 2013-06-27 Fertin Pharma A/S Method of releasing nicotine from chewing gum
JP6040218B2 (ja) 2012-02-23 2016-12-07 フロイント産業株式会社 口腔内崩壊錠用直打賦形剤及びその製造方法、並びに口腔内崩壊錠
WO2013171164A1 (en) 2012-05-14 2013-11-21 EJP Pharmaceutical ApS Compositions and formulations for the treatment of halitosis
US20160120793A1 (en) 2013-05-17 2016-05-05 Alequident Limited Oral Healthcare Product
US10357054B2 (en) 2013-10-16 2019-07-23 R.J. Reynolds Tobacco Company Smokeless tobacco pastille
EP3206671B1 (en) 2014-10-16 2024-06-12 Cargill, Incorporated Process for preparing a directly compressible erythritol and uses thereof
US9975847B2 (en) 2014-11-11 2018-05-22 Johnson & Johnson Consumer Inc. Amino acid derivatives and their uses
US11351103B2 (en) 2016-11-18 2022-06-07 Johnson & Johnson Consumer Inc. Method of providing oral care benefits
US10543205B2 (en) 2016-11-18 2020-01-28 Fertin Pharma A/S Oral delivery vehicle containing nicotine
US10632076B2 (en) 2016-11-18 2020-04-28 Fertin Pharma A/S Tablet comprising separate binder and erythritol
ES2870142T3 (es) 2016-11-18 2021-10-26 Fertin Pharma As Vehículo de administración oral
RU2736072C1 (ru) 2016-11-18 2020-11-11 Фертин Фарма А/С Таблетка, содержащая отдельное связывающее вещество и эритрит
US11135157B2 (en) 2018-05-17 2021-10-05 Fertin Pharma A/S Oral tablet for delivery of active ingredients to the throat
US11096895B2 (en) 2018-05-17 2021-08-24 Fertin Pharma A/S Oral tablet suitable for active pharmaceutical ingredients
US11058641B2 (en) 2018-05-17 2021-07-13 Fertin Pharma A/S Oral tablet for taste masking of active ingredients
CA3097953C (en) 2018-05-17 2023-09-12 Fertin Pharma A/S A tableted chewing gum suitable for active pharmaceutical ingredients
US11052047B2 (en) 2018-05-17 2021-07-06 Fertin Pharma A/S Oral tablet suitable for fast release of active pharmaceutical ingredients
US11096896B2 (en) 2018-05-17 2021-08-24 Fertin Pharma A/S Tablet dosage form for buccal absorption of active ingredients
US20190350858A1 (en) 2018-05-17 2019-11-21 Fertin Pharma A/S Oral tablet for delivery of active ingredients to the gastrointestinal tract
ES2966539T3 (es) 2019-04-17 2024-04-22 Nordiccan As Comprimido oral de cannabinoides

Also Published As

Publication number Publication date
BR112020023173A2 (pt) 2021-02-09
AU2019269879B2 (en) 2022-07-21
EP3773511A1 (en) 2021-02-17
CN112118834A (zh) 2020-12-22
KR20210010856A (ko) 2021-01-28
JP7403476B2 (ja) 2023-12-22
PL3773511T3 (pl) 2022-10-10
JP2021524438A (ja) 2021-09-13
CN112118834B (zh) 2024-01-02
EP4088716A1 (en) 2022-11-16
EP4088716C0 (en) 2024-10-16
KR102706980B1 (ko) 2024-09-19
US11096894B2 (en) 2021-08-24
EP3773511B1 (en) 2022-07-06
EP4088716B1 (en) 2024-10-16
CA3097055C (en) 2022-08-02
AU2019269879A1 (en) 2020-10-22
MX2020012280A (es) 2022-11-17
CA3097055A1 (en) 2019-11-21
WO2019219142A1 (en) 2019-11-21
US20190350859A1 (en) 2019-11-21
ES2926159T3 (es) 2022-10-24

Similar Documents

Publication Publication Date Title
PL3720418T3 (pl) Tabletka nikotynowa
IL259211A (en) Oral care implement
IL253840A0 (en) Oral treatment system
EP3965637C0 (en) DENTAL MOUTHPIECE
DK3875085T3 (da) Edaravon-suspension til oral indgivelse
EP3324928C0 (en) COMPOSITION FOR SELF-FILMOGENEOUS ORAL CARE
EP3823566C0 (en) ORAL APPLIANCE
EP3565502A4 (en) Oral irrigator
DK3634468T5 (da) Fast sammensætning til oral indgivelse
DK3920890T3 (da) Oral cannabinoid-tablet
EP3405405A4 (en) ORAL HYDRATION SYSTEM
EP4041122C0 (en) WATER INTERDENTAL CLEANER
MA44720A (fr) Comprimés à désintégration orale
DK3773511T3 (da) Oral tablet til induceret spytproduktion
IL291942A (en) Oral complement factor d inhibitors
IL283900A (en) Pharmaceutical combinations
PL3142493T3 (pl) Zaawansowane formowanie gum do żucia
EP3446684A4 (en) MELTING TABLET
EP3486117A4 (en) TABLE UNIT
DK3762009T3 (da) Toxin-afledte indgivelseskonstrukter til oral indgivelse
EP3678643A4 (en) SUBLINGUAL EPINEPHRINE TABLETS
DK3930663T3 (da) Mundplejeprodukt
IL252447B (en) Oral care composition
PL4077152T3 (pl) Jednostka produkcyjna
PL3965739T3 (pl) Postacie dawkowane będące tabletkami oleilofosfocholiny